Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Clinical Trial Set for AI-Driven Lung Fibrosis Drug

lung illustration

A clinical trial is set to begin testing the safety and chemical activity of a drug candidate for lung fibrosis, discovered and refined with artificial intelligence. . . . → Read More: Clinical Trial Set for AI-Driven Lung Fibrosis Drug

Trial Shows Immunotherapy Improves Lung Cancer Survival

Inspecting lung X-rays

Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy. . . . → Read More: Trial Shows Immunotherapy Improves Lung Cancer Survival

AI Process Discovers, Tests Fibrosis Drug in 18 Months

Human lungs illustration

A provider of drug discovery services based on artificial intelligence says in 18 months it identified and tested in mice a new drug for a chronic lung disease. . . . → Read More: AI Process Discovers, Tests Fibrosis Drug in 18 Months

Large Trial Testing Covid-19 Antibody Therapies

Global Covid-19

A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections. . . . → Read More: Large Trial Testing Covid-19 Antibody Therapies

AbbVie Acquires Coronavirus Antibody Therapy

SARS-Cov-2 virus

Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June. . . . → Read More: AbbVie Acquires Coronavirus Antibody Therapy

Infographic – Global Climate Technology Hubs

Chart: climate tech hubs

The report also highlights where the investments were made, with the geographic hubs or clusters attracting the most investments, this weekend’s infographic. . . . → Read More: Infographic – Global Climate Technology Hubs

Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Lab mouse

Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells. . . . → Read More: Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Glove-App System Translates Sign Language to Speech

Sign language translation glove

University engineers designed a glove with electronic sensors that sends signals to a smartphone app to translate American Sign Language into audible speech. . . . → Read More: Glove-App System Translates Sign Language to Speech

Covid-19 Vaccine for Lower-Income Regions Underway

Robin Shattock

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

Industry, Univ. Labs Partner on Covid-19 Therapy

Covid-19 illustration

Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine. . . . → Read More: Industry, Univ. Labs Partner on Covid-19 Therapy